- Report
- May 2024
- 93 Pages
Global
From €2282EUR$2,400USD£1,917GBP
- Report
- January 2025
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- June 2021
- 129 Pages
Global
From €2614EUR$2,750USD£2,196GBP
€5229EUR$5,500USD£4,393GBP
- Report
- November 2023
- 60 Pages
Global
From €2282EUR$2,400USD£1,917GBP
- Drug Pipelines
- July 2020
- 33 Pages
Global
From €3327EUR$3,500USD£2,795GBP
- Drug Pipelines
- June 2020
- 34 Pages
Global
From €3327EUR$3,500USD£2,795GBP
- Drug Pipelines
- February 2020
- 65 Pages
Global
From €3327EUR$3,500USD£2,795GBP
- Drug Pipelines
- January 2020
- 112 Pages
Global
From €3327EUR$3,500USD£2,795GBP
- Drug Pipelines
- December 2019
- 63 Pages
Global
From €3327EUR$3,500USD£2,795GBP
- Drug Pipelines
- November 2018
- 47 Pages
Global
From €3327EUR$3,500USD£2,795GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- January 2024
- 120 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Drug Pipelines
- January 2024
- 90 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP

Protein Kinases are a type of enzyme that catalyzes the transfer of phosphate groups from high-energy donor molecules to proteins. They are involved in a wide range of cellular processes, including cell growth, differentiation, and metabolism. Protein Kinases are also involved in signal transduction pathways, which are essential for the regulation of cell behavior. Protein Kinases are important drug targets for the treatment of various diseases, including cancer, diabetes, and cardiovascular diseases.
The Protein Kinases market is a rapidly growing segment of the enzymes market. It is driven by the increasing prevalence of chronic diseases, the growing demand for targeted therapies, and the development of novel technologies for drug discovery. The market is also driven by the increasing demand for protein kinase inhibitors, which are used to treat various diseases.
Some of the major companies in the Protein Kinases market include Merck & Co., Inc., Pfizer Inc., Novartis AG, AstraZeneca plc, and Bristol-Myers Squibb Company. Show Less Read more